Article info

Download PDFPDF

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Authors

  • Rachel E. Sanborn Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center Portland OR USA Earle A. Chiles Research Institute N.E. Glisan Street, 2N35 97213 Portland OR USA PubMed articlesGoogle scholar articles
  • Helen J. Ross Mayo Clinic Arizona Phoenix AZ USA PubMed articlesGoogle scholar articles
  • Sandra Aung UbiVac Portland OR USA Present address: Nektar Therapeutics San Francisco USA PubMed articlesGoogle scholar articles
  • Anupama Acheson Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center Portland OR USA PubMed articlesGoogle scholar articles
  • Tarsem Moudgil Laboratory of Molecular and Tumor ImmunologyRobert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center Portland OR USA PubMed articlesGoogle scholar articles
  • Sachin Puri Laboratory of Molecular and Tumor ImmunologyRobert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center Portland OR USA PubMed articlesGoogle scholar articles
  • Traci Hilton UbiVac Portland OR USA PubMed articlesGoogle scholar articles
  • Brenda Fisher Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center Portland OR USA PubMed articlesGoogle scholar articles
  • Todd Coffey Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center Portland OR USA PubMed articlesGoogle scholar articles
  • Christopher Paustian Laboratory of Molecular and Tumor ImmunologyRobert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center Portland OR USA PubMed articlesGoogle scholar articles
  • Michael Neuberger Laboratory of Molecular and Tumor ImmunologyRobert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center Portland OR USA Present address: Department of General, Visceral and Transplantation SurgeryUniversity of Munich Campus Grosshadern Munich Germany PubMed articlesGoogle scholar articles
  • Edwin Walker Immunological Monitoring LaboratoryRobert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center Portland OR USA PubMed articlesGoogle scholar articles
  • Hong-Ming Hu UbiVac Portland OR USA Laboratory of Cancer ImmunobiologyRobert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center Portland OR USA PubMed articlesGoogle scholar articles
  • Walter J. Urba Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center Portland OR USA PubMed articlesGoogle scholar articles
  • Bernard A. Fox UbiVac Portland OR USA Laboratory of Molecular and Tumor ImmunologyRobert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center Portland OR USA Department of Molecular Microbiology and Immunology; and Knight Cancer InstituteOregon Health and Science University Portland OR USA PubMed articlesGoogle scholar articles
  1. a +001 503 215 6614 Rachel.sanborn{at}providence.org
  2. b Ross.Helen{at}mayo.edu
  3. c SAung{at}nektar.com
  4. d Anupama.Acheson{at}providence.org
  5. e Tarsem.Moudgil{at}providence.org
  6. f sachinpuri15{at}yahoo.com
  7. g traci.hilton{at}ubivac.com
  8. h Brenda.Fisher{at}providence.org
  9. i tcoffey{at}idahocom.org
  10. j christopher.paustian{at}ubivac.com
  11. k neuberger.privat{at}freenet.de
  12. l edwin.b.walker{at}gmail.com
  13. m Hong-Ming.Hu{at}providence.org
  14. n Walter.Urba{at}providence.org
  15. o Bernard.Fox{at}providence.org
View Full Text

Citation

Sanborn RE, Ross HJ, Aung S, et al
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Publication history

  • Received July 10, 2017
  • Accepted November 29, 2017
  • First published December 19, 2017.
Online issue publication 
December 19, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.